M&A

M&A
  • Viral impact: How the coronavirus is affecting M&A and private equity
    March 18, 2020 9:45 AM

    The Dow Jones plunged more than 1,200 points, as the number of worldwide coronavirus cases soars. To gauge how the middle market is viewing ongoing developments, we seek insights from dealmakers at Alvarez & Marsal, Riverside Co., Merrill Corp. and Paul Hastings.

    12 Min Read
    Paul Davis
    March 16, 2020 5:01 PM

    First Horizon, Pacific Premier and South State are warning in regulatory filings that the pandemic could complicate deals that have not been completed.

    2 Min Read
    Ken McCarthy
    March 13, 2020 1:03 PM

    Coronavirus concerns, along with the Fed's emergency rate cut and an erratic stock market, have forced most bankers to take pause and reassess potential deals.

    3 Min Read
    M&A wrap: PepsiCo, Rockstar, Coronavirus, Riverside, Gladstone, Marlin Equity, Merrill, Paul Hastings
    March 11, 2020 11:12 AM

    Investors fear the coronavirus may end the bear market. We check in with dealmakers from Riverside, Merrill Corp. and Paul Hastings about the potential impact on mid-market M&A. In deal news, Pepsi buys Rockstar to expand energy drink line.

    6 Min Read
    M&A wrap: Blackstone, Houlihan Lokey, Lincoln, Audax, Genstar, AEI, Vista, Summit, PE fundraising
    March 4, 2020 10:51 AM

    Private capital fundraising posted a banner year in 2019 led Blackstone closing the largest buyout fund ever. AEI, Vista, Summit, involved in PE-related deals. Houlihan Lokey and Lincoln among top investment banks. Audax and Genstar rank among top PE firms.

    8 Min Read
    M&A wrap: Thermo Fisher, Qiagen, Coronavirus, Bregal Sagemount, AEI, GTCR, FP, Riverside, Merrill, Paul Hastings, Houlihan Lokey, Audax
    March 3, 2020 11:02 AM

    Thermo Fisher buys coronavirus test maker Qiagen in biggest healthcare of the deal of the year. Bregal Sagemount raises third fund. In more PE news, AEI, GTCR and FP make deals.

    9 Min Read
    Thermo Fisher buys coronavirus test maker Qiagen for $10 billion
    By Bloomberg News
    March 3, 2020 9:12 AM

    When a new coronavirus emerged out of China in January, Qiagen got to work on a test to detect the virus in bodily fluids. The test is now being evaluated at four hospitals in China and one in France. The diagnostic gives results in about one hour.

    1 Min Read
    M&A wrap: Houlihan Lokey, Lincoln, Jefferies, William Blair, Piper Sandler, BV, Jack Welch, GE, Gilead, KKR, Palladium, Odyssey, Coronavirus
    March 2, 2020 11:47 AM

    Stock market volatility continues, as investors gauge the impact of the coronavirus on the global economy. We turn to dealmakers from Riverside, Merrill Corp. and Paul Hastings for insights on how the virus will affect the middle market. Houlihan Lokey, headquartered in Los Angeles, tops the list of most active investment banks in PE-backed deals. Audax, in Boston, ranks as No. 1 in PE firms doing U.S. deals.

    8 Min Read
    M&A wrap: Corsair, Blackstone, Goldman Sachs, Seabury, McAfee, Wynnchurch, Audax, Coronavirus
    February 26, 2020 10:44 AM

    Stock market volatility underscores fears of global shortages of manufactured goods due to the coronavirus. We check in with dealmakers on the potential impact. Corsair Capital raises fifth fund. Audax, HarbourVest and Genstar named top three most active PE firms in U.S. deals.

    9 Min Read
    Jamie Dimon
    February 26, 2020 7:57 AM

    JPMorgan would consider buying other businesses; collectors would be allowed to pursue debt past the statute of limitations, if they warn borrowers.

    6 Min Read